Search for: "Watson v. Doj"
Results 1 - 20
of 23
Sorted by Relevance
|
Sort by Date
11 Sep 2020, 6:58 am
Watson v. [read post]
12 Aug 2020, 7:43 am
Counselors v. [read post]
22 May 2017, 12:00 pm
In Zakharov v. [read post]
14 Nov 2016, 9:16 am
Watson Laboratories, Inc., No. 16-493 (pre-AIA, do secret sales count as prior art?) [read post]
29 Aug 2022, 9:05 pm
Still, the FTC and DOJ do not appear deterred. [read post]
18 Jun 2007, 1:00 am
Supreme Court, in Kelo v. [read post]
3 Nov 2010, 1:21 am
Pharmachemie (EPLAW) US: Supreme Court to hear Bayh-Dole patent ownership dispute: Stanford v Roche (Patently-O) (IPKat) (IPBiz) US: DoJ amicus brief in Myriad says no to patentability of genomic DNA: AMP v USPTO (IPBiz) (Inventive Step) (Patently-O) (Patent Docs) (Holman’s Biotech IP Blog) US: Briefing update: AMP v USPTO (Patent Docs) US: BIO and AUTM file amicus brief in Myriad case (PatentlyBIOtech) US: Myriad files appeal brief in AMP v USPTO… [read post]
22 Mar 2019, 6:27 am
Posted by Cydney Posner, Cooley LLP, on Sunday, March 17, 2019 Tags: Accountable Capitalism Act, Citizens United v. [read post]
9 Apr 2009, 7:52 am
(Part I - Patent Circle) (Part II – Patent Circle) Indian biogenerics on an upswing – US Promoting Innovation and Access to Life-Saving Medicine Act (Patent Baristas) US: Anti-reverse payment legislation Protecting Consumer Access to Generic Drugs Act of 2009 introduced in the House (Patent Docs) US: CAFC clarifies obviousness standard in context of cDNA cloning invention: In re Kubin (Holman's Biotech IP Blog) (Patent Docs) (Hal Wegner) (Philip Brooks' Patent… [read post]
22 Jul 2009, 6:05 am
(PatLit) Levaquin (Levofloxacin) – US: CAFC awards only partial costs where depositions used in multiple cases from different district courts: Ortho-McNeil Pharmaceutical, Inc. v. [read post]
26 Nov 2012, 2:38 am
Watson (D. [read post]
1 May 2012, 6:49 pm
First, in Geico General Insurance Co. v. [read post]
9 Apr 2022, 3:01 am
Doe v. [read post]
15 Nov 2007, 1:21 am
The suit, Byers v. [read post]
5 Jul 2023, 7:45 am
That is exactly the Department of Justice’s argument in its response brief: that its new rule is completely different from the prior administration’s “bar,” because according to DOJ, the new rule “does not treat manner of entry as dispositive, but instead creates a rebuttable presumption that can be overcome…”4 So the “Mother, may I? [read post]
6 Oct 2013, 2:00 pm
“[A] copy of all [CIA] records pertaining to the IBM supercomputer ‘Watson. [read post]
21 Jul 2017, 6:04 am
Pastuszenski, Goodwin Procter LLP, on Tuesday, July 18, 2017 Tags: California, Class actions, Jurisdiction, New York, PSLRA, Securities Act, Securities litigation, Shareholder suits, SLUSA, State law, Supreme Court CalPERS v. [read post]
21 Feb 2020, 6:13 am
Silk, and Sabastian V. [read post]
22 Jul 2016, 6:10 am
., Fried, Frank, Harris, Shriver & Jacobson LLP, on Tuesday, July 19, 2016 Tags: Antitrust, Disclosure, DOJ, Engagement, Executive Compensation, Hart-Scott-Rodino Act, Mergers & acquisitions,Schedule 13D, Securities enforcement, Securities regulation, Settlements, Shareholder activism, Shareholder rights,Shareholder voting Hot Topics for Boards from the 2016 Proxy Season Posted by Holly J. [read post]
24 Apr 2017, 8:33 am
And with respect to the President, in particular, it is what undergirds the Supreme Court’s decision in Clinton v. [read post]
